ClinicalTrials.gg
Drug

Flotufolastat F 18 clinical trials

Also written Posluma and flotufolastat F18.

Its developmentBy Bracco, Sinotau Pharmaceutical Group and Novartis, step by step7 company-led studies, furthest phase 4: when each phase was reached, its deals, target and what is ahead.
studies test it
17
open now
7
in phase 3
4
first study started
2019

How each study uses flotufolastat F 18 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the flotufolastat F 18 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

rhPSMA-7.3 (18F)
5
18F-rhPSMA-7.3
5
rhPSMA-7.3 (18F) Injection
3
Fluorine F 18 rhPSMA-7.3
3
(18F)-rhPSMA-7.3
3

Brand

Posluma
5

Development codes

RHPSMA-7.3C
1

Other names

flotufolastat F18
2

Studies by the year they started

17 studies that test it; most in 2025 (8)

Studies that test flotufolastat F 18, by start year
YearStudies
20191
20202
20211
20232
20241
20258
20262

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
4
Phase 2
5
Phase 3
4
Phase 4
1
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 7 · Other 10

Blue Earth Diagnostics (4) · Sinotau Pharmaceutical Group (2) · NYU Langone Health (1) · M.D. Anderson Cancer Center (1) · Jonsson Comprehensive Cancer Center (1) · Emory University (1) · Northwestern University (1) · University of Florida (1)

Often tested with

Tested in the same studies.

Piflufolastat (1) · Lutetium-177 (1) · Gallium 68 PSMA-11 (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2

Studies that test flotufolastat F 18.

Studies

Open first, then newest update. How each study uses flotufolastat F 18 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 17

Codes

What other systems call flotufolastat F 18 · ClinicalTrials.gg INT002169

  • MeSH (NLM) C000731939flotufolastat F 18One source NLM
  • UNII (FDA) 811W19E3OLFLOTUFOLASTAT F-18Confirmed FDA, NLM, Wikidata
  • Wikidata Q120497866flotufolastat F-18Confirmed FDA, NLM, Wikidata
  • Wikidata Q120693652flotufolastatConfirmed FDA, NLM, Wikidata
  • DrugBank DB17851One source Wikidata

Also registered as flotufolastat f-18 gallium (UNII XD423NK2WO).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.